Breathe-5:: Bosentan improves hemodynamics and exercise capacity in the first randomized placebo-controlled trial in Eisenmenger physiology

被引：10
|
作者：
Galiè, N [1 ]
Beghetti, M [1 ]
Gatzonlis, N [1 ]
Granton, J [1 ]
Berger, R [1 ]
Lauer, A [1 ]
Chiossi, E [1 ]
Landzberg, M [1 ]
机构：
[1] Univ Bologna, I-40126 Bologna, Italy
来源：
CHEST | 2005年 / 128卷 / 04期
关键词：
D O I：
10.1378/chest.128.4_MeetingAbstracts.496S
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：496S / 496S
页数：1
相关论文
共 50 条
  • [1] Bosentan improves hemodynamics and exercise capacity in Eisenmenger physiology
    Landzberg, M
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 246A - 246A
  • [2] Bosentan shows persistent benefit in functional class and exercise capacity amongst Eisenmenger patients in the BREATHE-5 open label extension study
    Gatzoulis, M. A.
    Beghetti, M.
    Galie, N.
    Granton, J.
    Berger, R.
    Lauer, A.
    Chiossi, E.
    Landzberg, M. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 8 - 9
  • [3] Bosentan, a dual endothelin receptor antagonist, improves exercise capacity and hemodynamics in patients with pulmonary arterial hypertension: Results of a double blind, randomized, placebo-controlled trial
    Channick, RN
    Rubin, LJ
    Simonneau, G
    Robbins, I
    Tapson, V
    Frost, A
    Badesch, DB
    Bodin, F
    Roux, SP
    CIRCULATION, 2000, 102 (18) : 100 - 100
  • [4] Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome:: Results of the BREATHE-5 open-label extension study
    Gatzoulis, Michael A.
    Beghetti, Maurice
    Galie, Nazzareno
    Granton, John
    Berger, Rolf M. F.
    Lauer, Andrea
    Chiossi, Eleonora
    Landzberg, Michael
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 127 (01) : 27 - 32
  • [5] Combination therapy with bosentan and sildenafil in Eisenmenger syndrome: a randomized, placebo-controlled, double-blinded trial
    Iversen, Kasper
    Jensen, Annette S.
    Jensen, Tim V.
    Vejlstrup, Niels G.
    Sondergaard, Lars
    EUROPEAN HEART JOURNAL, 2010, 31 (09) : 1124 - 1131
  • [6] Candesartan Improves Maximal Exercise Capacity in Hypertensives: Results of a Randomized Placebo-Controlled Crossover Trial
    De Rosa, Maria Leonarda
    Chiariello, Massimo
    JOURNAL OF CLINICAL HYPERTENSION, 2009, 11 (04): : 192 - 200
  • [7] Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF Results of the Randomized Placebo-Controlled HELP Trial
    Burkhoff, Daniel
    Borlaug, Barry A.
    Shah, Sanjiv J.
    Zolty, Ronald
    Tedford, Ryan J.
    Thenappan, Thenappan
    Zamanian, Roham T.
    Mazurek, Jeremy A.
    Rich, Jonathan D.
    Simon, Marc A.
    Chung, Eugene S.
    Raza, Farhan
    Majure, David T.
    Lewis, Gregory D.
    Preston, Ioana R.
    Rich, Stuart
    JACC-HEART FAILURE, 2021, 9 (05) : 360 - 370
  • [8] Bosentan therapy in patients with Eisenmenger syndrome - A multicenter, double-blind, randomized, placebo-controlled study
    Galie, Nazzareno
    Beghetti, Maurice
    Gatzoulis, Michael A.
    Granton, John
    Berger, Rolf M. F.
    Lauer, Andrea
    Chiossi, Eleonora
    Landzberg, Michael
    CIRCULATION, 2006, 114 (01) : 48 - 54
  • [9] Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: A subgroup analysis
    Berger, Rolf M. F.
    Beghetti, Maurice
    Galie, Nazzareno
    Gatzoulis, Michael A.
    Granton, John
    Lauer, Andrea
    Chiossi, Eleonora
    Landzberg, Michael
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 144 (03) : 373 - 378
  • [10] Pentoxifylline Improves Nonalcoholic Steatohepatitis: A Randomized Placebo-Controlled Trial
    Zein, Claudia O.
    Yerian, Lisa M.
    Gogate, Prema
    Lopez, Rocio
    Kirwan, John P.
    Feldstein, Ariel E.
    McCullough, Arthur J.
    HEPATOLOGY, 2011, 54 (05) : 1610 - 1619
12345